CalciMedica Inc. (NASDAQ: CALC) Stock Information | RedChip

CalciMedica Inc. (NASDAQ: CALC) Listen to this Section


$4.04
-0.0650 ( -1.59% ) 10.4K

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

Market Data


Open


$4.04

Previous close


$4.10

Volume


10.4K

Market cap


$45.02M

Day range


$4.10 - $4.33

52 week range


$1.75 - $8.38

Insider Ownership Transactions

Total Amount Purchased: 196,972.00 | $ 794,782.02

Date Type Amount Purchased Purchaser
2024-04-22 Sale -10000.00 BJERKHOLT ERIC
2024-04-22 Sale -10000.00 WILSON ROBERT N
2024-04-22 Sale -10000.00 MIDDLETON FRED A
2024-04-22 Sale -10000.00 Shaw Allan
2024-04-02 Buy 746.00 Roberts Eric W
2024-02-06 Sale -91086.00 Roberts Eric W
2024-01-25 Buy 243356.00 MIDDLETON FRED A
2024-01-25 Buy 243356.00 Sanderling Venture Partners VI LP
2024-01-25 Sale -68314.00 WILSON ROBERT N
2024-01-25 Sale -91086.00 Leheny A. Rachel

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 13 May 13, 2024
10-k/a Quarterly Reports 17 Apr 29, 2024
4 Insider transactions 1 Apr 22, 2024
4 Insider transactions 1 Apr 22, 2024
4 Insider transactions 1 Apr 22, 2024
4 Insider transactions 1 Apr 22, 2024
4 Insider transactions 1 Apr 22, 2024
4 Insider transactions 1 Apr 22, 2024
4 Insider transactions 1 Apr 22, 2024
4 Insider transactions 1 Apr 22, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.